当前位置:首页 - 行情中心 - 科源制药(301281) - 财务分析

科源制药

(301281)

  

流通市值:25.62亿  总市值:40.29亿
流通股本:6885.20万   总股本:1.08亿

科源制药(301281)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.40亿元,每股收益0.37元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益133747.77万元,未分配利润27272.59万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产146466.82万元,负债12719.04万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入330,879,995.68237,142,859.74146,276,963.82447,583,620.32
营业总成本303,707,035.89211,807,312.62124,459,548.73381,057,260.02
营业利润45,779,440.8442,467,943.1224,428,408.7880,116,576.65
利润总额42,917,141.4640,737,829.9623,229,047.3679,735,057.72
净利润39,555,461.0936,027,184.1221,523,763.0677,039,439.15
其他综合收益----
综合收益总额39,555,461.0936,027,184.1221,523,763.0677,039,439.15
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计643,859,810.97710,579,541.14830,437,539.4878,788,621.84
非流动资产合计820,808,350.76758,032,179.21673,432,100.13591,179,352.17
资产总计1,464,668,161.731,468,611,720.351,503,869,639.531,469,967,974.01
流动负债合计99,136,243.47105,760,807.24125,506,446.68111,143,089.84
非流动负债合计28,054,190.2629,357,642.4726,532,341.4927,784,636.63
负债合计127,190,433.73135,118,449.71152,038,788.17138,927,726.47
归属于母公司股东权益合计1,336,620,591.671,332,572,437.031,350,854,873.841,331,040,247.54
股东权益合计1,337,477,7281,333,493,270.641,351,830,851.361,331,040,247.54
负债和股东权益合计1,464,668,161.731,468,611,720.351,503,869,639.531,469,967,974.01
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计271,653,032.95190,116,391.6488,320,171.72385,704,878.03
经营活动现金流出小计247,782,116.39172,178,593.5789,961,054.86348,673,888.21
经营活动产生的现金流量净额23,870,916.5617,937,798.07-1,640,883.1437,030,989.82
投资活动现金流入小计861,878,324.86506,296,462.373,527,905,218.34659,300,286.47
投资活动现金流出小计911,548,188.84640,172,339.933,318,488,995.971,261,426,908.11
投资活动产生的现金流量净额-49,669,863.98-133,875,877.56209,416,222.37-602,126,621.64
筹资活动现金流入小计1,000,0001,000,0001,000,000782,943,530
筹资活动现金流出小计32,487,820.7232,487,820.72-43,135,562.8
筹资活动产生的现金流量净额-31,487,820.72-31,487,820.721,000,000739,807,967.2
汇率变动对现金及现金等价物的影响381,826.89-30,335.11261,598.54522,555.42
现金及现金等价物净增加额-56,904,941.25-147,456,235.32209,036,937.77175,234,890.8
期末现金及现金等价物余额267,304,173.29176,752,879.22568,547,454.88324,209,114.54
TOP↑